A Retrospective Real-world Study of Abemaciclib Tablets Based on HIS System in HR+ Breast Cancer Patients
Conditions: Breast Cancer; Neoplasms; Breast Diseases Interventions: Drug: Abemaciclib and Letrozole/Anastrozole; Drug: Letrozole or Anastrozole; Drug: Abemaciclib and Fulvestrant; Drug: Fulvestrant Sponsors: The Affiliated Hospital of Qingdao University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Brain Blood Flow Responses to Stress: Sex Differences
Conditions: Cerebrovascular Disorders Interventions: Drug: Indomethacin; Drug: Placebo; Drug: Orilissa; Drug: Testosterone gel; Drug: Anastrozole; Drug: Estradiol Sponsors: University of Wisconsin, Madison; National Heart, Lung, and Blood Institute (NHLBI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBC
Conditions: Breast Neoplasms Interventions: Drug: Darcilide +AI (letrozole/anastrozole/Exemestane) + pyrrotinib Sponsors: Second Affiliated Hospital of Soochow University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer
Conditions: Breast Cancer Interventions: Drug: Letrozole; Drug: Anastrozole; Drug: Exemestane; Drug: Tamoxifen Sponsors: Region Örebro County; Mid-Sweden Regional Cancer Centre; Akademiska University Hospital, Uppsala, Sweden Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
Conditions: Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Locally Advanced Unresectable HER2-Negative Breast Carcinoma; Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma; Metastatic HER2-Negative Breast Carcinoma; Metastatic Hormone Receptor-Positive Breast Carcinoma Interventions: Drug: Abemaciclib; Drug: Anastrozole; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Diagnostic Imaging; Drug: Exemestane; Other: Fludeoxyglucose F-18; Drug: Fluorine F 18 Fluoro Furanyl Norprogesterone; Drug: Fulvestrant; Biological: Gonadotropin-releasin...
Source: ClinicalTrials.gov - December 21, 2023 Category: Research Source Type: clinical trials
Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor
Conditions: Metastatic Breast Cancer; Tumor; Muscle Neoplasms; Chronic Pain Interventions: Drug: Method(s)1 Attribution; Drug: Method(s)2 Attribution, Sponsors: DR. DIANE CHISESI NFS. MD. PHD.; IRB Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
Study of 18F-FFNP Breast PET/MRI
Conditions: Breast Cancer Interventions: Drug: 18F-fluorofuranylnorprogesterone; Device: Positron Emissions Tomography / Magnetic Resonance Imaging; Drug: Anastrozole; Other: Blood Sampling; Drug: Gadobenate dimeglumine Sponsors: University of Wisconsin, Madison; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Conditions: Breast Cancer; Advanced Breast Cancer; Metastatic Breast Cancer; ER Positive Breast Cancer; HER2 Negative Breast Carcinoma Interventions: Drug: OP-1250; Drug: Fulvestrant; Drug: Anastrozole; Drug: Letrozole; Drug: Exemestane Sponsor: Olema Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials
